Anti-CD19 CAR T-Cell (CNCT19) Infusion Following HDT/ASCT Is Safe and Effective in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Category Primary study
JournalBlood
Year 2020
This article has no abstract
Epistemonikos ID: a3265ad1482d10c146264162594c9990c2008050
First added on: Feb 12, 2025